• Non ci sono risultati.

Lo studio ICoNA è realizzato con il supporto di Glaxo Smith Kline. Partecipanti allo studio ICoNA

Ancona: M Montroni, G Scalise, MC Braschi, A Riva. Aviano (PN): U Tirelli, R Cinelli. Bari: G

Pastore, N Ladisa, G Minafra. Bergamo: F Suter, C Arici. Bologna: F Chiodo, V Colangeli, C Fiorini, O

Coronado. Brescia: G Carosi, GP Cadeo, C Torti, C Minardi, D Bertelli. Busto Arsizio (VA): G Rizzardini,

S Melzi. Cagliari: PE Manconi, P Piano. Catanzaro: L Cosco, A Scerbo. Chieti: J Vecchiet, M

D’Alessandro. Como: D Santoro, L Pusterla. Cremona: G Carnevale, P Citterio. Cuggiono (MI): P

Viganò, M Mena. Ferrara: F Ghinelli, L Sighinolfi. Firenze: F Leoncini, F Mazzotta, M Pozzi, S Lo

Caputo. Foggia: G Angarano, B Grisorio, A Saracino, S Ferrara. Galatina (LE): P Grima, P Tundo.

Genova: G Pagano, G Cassola, A Alessandrini, R Piscopo. Grosseto: M Toti, S Chigiotti. Latina: F Soscia,

L Tacconi. Lecco: A Orani, P Perini. Lucca: A Scasso, A Vincenti. Macerata: F Chiodera, P Castelli.

Mantova: A Scalzini, L Palvarini. Milano: M Moroni, A Lazzarin, A Cargnel, GM Vigevani, L Caggese, A

d’Arminio Monforte, D Repetto, A Galli, S Merli, C Pastecchia, MC Moioli. Modena: R Esposito, C

Mussini. Napoli: N Abrescia, A Chirianni, CM Izzo, M Piazza, M De Marco, R Viglietti, E Manzillo, S

Nappa. Palermo: A Colomba, V Abbadessa, T Prestileo, S Mancuso. Parma: C Ferrari, P Pizzaferri. Pavia:

G Filice, L Minoli, R Bruno, S Novati. Perugia: F Baldelli, M Tinca. Pesaro: E Petrelli, A Cioppi.

Piacenza: F Alberici, A Ruggieri. Pisa: F Menichetti, C Martinelli. Potenza: C De Stefano, A La Gala.

Ravenna: G Ballardini, E Rizzo. Reggio Emilia: G Magnani, MA Ursitti. Rimini: M Arlotti, P Ortolani.

Roma: R Cauda, F Dianzani, G Ippolito, A Antinori, G Antonucci, S D’Elia, P Narciso, N Petrosillo, V

Vullo, A De Luca, A Bacarelli, M Zaccarelli, R Acinapura, P De Longis, A Brandi, MP Trotta, P Noto, M

Lichtner, MR Capobianchi, F Carletti, E Girardi, P Pezzotti, G Rezza. Sassari: MS Mura, M Mannazzu.

Torino: P Caramello, G Di Perri, ML Soranzo, GC Orofino, I Arnaudo, M Bonasso. Varese: PA Grossi, C

Basilico. Verbania: A Poggio, G Bottari. Venezia: E Raise, F Ebo. Vicenza: F De Lalla, G Tositti.

Taranto: F Resta, K Loso. London: A Cozzi Lepri.

Bibliografia

1. Joint United Nations Programme on HIV/AIDS and World Health Organization. Global AIDS

Epidemic Update: December 2004. Geneva: UNAIDS/WHO; 2004.

2. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO,

Lutalo T, Gray RH. Viral load and heterosexual transmission of human immunodeficiency virus type

1. N Engl J Med 2000;342:921-9.

3. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, Ho DD. Genetic characterization

of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral

compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-107.

4. Gupta P, Mellors J, Kingsley L, Riddler S, Singh MK, Schreiber S, Cronin M, Rinaldo CR. High

viral load in semen of human immunodeficiency virus type 1–infected men at all stages of disease

and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol

1997;71:6271-5.

5. Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K, Pomerantz RJ.

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral

therapy. N Engl J Med 1998;339:1803-9.

6. Lampinen TM, Critchlow CW, Kuypers JM, Hurt CS, Nelson PJ, Hawes SE, Coombs RW, Holmes

KK, Kiviat NB. Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the

anorectal mucosa of homosexual men. AIDS 2000;14:F69-F75.

7. Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang CY. Decreased

HIV transmission after a policy of providing free access to highly active antiretroviral therapy in

Taiwan. J Infect Dis 2004;190:879-85.

8. Calzavara L, Burchell AN, Major C, Remis RS, Corey P, Myers T, Millson P, Wallace E. Increases

in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in

Ontario, Canada. AIDS 2002;16:1655-61

9. Dukers NH, Spaargaren J, Geskus RB, Beijnen J, Coutinho RA, Fennema HS. HIV incidence on the

increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using

a novel approach for detecting recent infections. AIDS 2002;16:F19-24.

10. Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, McFarland W. Impact of

highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San

Francisco. Am J Public Health 2002;92:388-94.

11. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in

San Francisco. Science 2000;287:650-4.

12. Centers for Disease Control and Prevention. Increases in unsafe sex and rectal gonorrhea among men

who have sex with men— San Francisco, California, 1994-1997. MMWR 1999;48:45-8.

13. Dodds JP, Nardone A, Mercey DE, Johnson AM. Increase in high risk sexual behaviour among

homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ 2000;320:1510-1.

14. Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, Stoyanoff SR,

LaLota M, Celentano DD, Koblin BA, Thiede H, Katz MH, Torian LV, Janssen RS. HIV prevalence

and associated risks in young men who have sex with men. JAMA 2000;284:198-204.

15. van der Straten A, Gomez CA, Saul J, Quan J, Padian N. Sexual risk behaviors among eterosexual

HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy.

AIDS 2000;14:F47-F54.

16. Stolte IG, Dukers NHTM, de Wit JBF, Fennema JSH, Coutinho RA. Increase in sexually transmitted

infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect

2001;77:184-6.

17. Rietmeijer CA, Patnaik JL, Judson FN, Douglas JM Jr. Increases in gonorrhea and sexual risk

behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health

Clinic. Sex Transm Dis 2003;30:562-7.

18. Centers for Disease Control and Prevention. Trends in primary and secondary syphilis and HIV

infections in men who have sex with men--San Francisco and Los Angeles, California, 1998-2002.

MMWR 2004;53:575-8.

19. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a

meta-analytic review. JAMA 2004;292:224-36.

20. d’Arminio Monforte A, Cozzi Lepri A, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G,

Colangeli V, De Luca A, Ippolito G, Caggese L, Soscia F, Filice G, Gritti F, Narciso P, Tirelli U,

Moroni M for the I.CO.N.A. Study Group. Insights into the reasons for discontinuation of the first

highly active antiretrovial therapy (HAART) regimen in a cohort of antiretroviral naive patients.

AIDS 2000;14:499-507.

21. Girardi E, Aloisi MS, Serraino D, Ferrara M, Lauria FN, Carballo M, d’Arminio Monforte A, Rezza

G, Moroni M, Carosi G, Alessandrini A, Giacobbi D, Cremonini L, Ranieri S, Montroni M, Ippolito

G. Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy

in Italy. Sex Transm Infect 2001;77:130-4.

22. Aloisi MS, Arici C, Balzano R, Noto P, Piscopo R,Filice G, Menichetti F, d’Arminio Monforte

A,Ippolito G, Girardi E. Behavioural correlates of adherence to antiretroviral therapy. J Acquir

Immune Defic Syndr 2002;31:S145-8.

23. Aloisi MS, Girardi E, Serraino D, Ferrara M, Ortolani P, Tositti G, Tacconi L, Fibbia GC, Sighinolfi

L, Ippolito G. Sexual risk behaviuors after initiating HAART therapy among people living with HIV.

XIV International AIDS Conference, Barcelona (Spain) July 7-12,2002. Abstract ThPeD 7765.

24. Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, Vigevano G, Alberici F, Ursitti M,

D’Alessandro M, d’Arminio Monforte A, Ippolito G for the I.Co.N.A. Behavioural Epidemiology

Study Group. Delayed presentation and late testing for HIV: demographic and behavioural risk

factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004;36:951-9.

Documenti correlati